compounded glp 1 drugs GLP-1s Become Illegal, Price Cuts Roll Out Effective GLP 1 Meds for
Description
Dutta, P., Kumar, Y., Babu, A
Mornigo R, Vidal J, Lacy AM, Delgado S, Casamitjana R, Gomis R
Absolute risk increase approximately 0.7 percentage points
They were initially developed to manage type 2 diabetes, but are now being explored for a broader range of uses, most popularly, in weight management but also importantly, in cardiovascular health
FDA cleared its Phase 1 Investigational New Drug application on June 23, 2026
